Cited by 162

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Age-dependent neuronal and synaptic degeneration in mice transgenic for the C terminus of the amyloid precursor protein.

Oster-Granite, Mary Lou, McPhie, Donna L., Greenan, Jane, Neve, Rachael L.·1996·The Journal of Neuroscience

Abstract

The molecular basis for the degeneration of neurons and the deposition of amyloid in plaques and in the cerebrovasculature in Alzheimer’s disease (AD) is incompletely understood. We have proposed that one molecule common to these abnormal processes is a fragment of the Alzheimer amyloid precursor protein (APP) comprising the C-terminal 100 amino acids of this molecule (APP-C100). We tested this hypothesis by creating transgenic mice expressing APP-C100 in the brain. We report here that aging (18–28 month) APP-C100 transgenic mice exhibit profound degeneration of neurons and synapses in Ammon’s horn and the dentate gyrus of the hippocampal formation. Of the 106 transgenic mice between 8 and 28 months of age that were examined, all of those older than 18 months displayed severe hippocampal degeneration. The numerous degenerating axonal profiles contained increased numbers of neurofilaments, whorls of membrane, and accumulations of debris resembling secondary lysosomes near the cell body. The dendrites of degenerating granule and pyramidal cells contained disorganized, wavy microtubules. Cerebral blood vessels had thickened refractile basal laminae, and microglia laden with debris lay adjacent to larger venous vessels. Mice transgenic for Flag-APP-C100 (in which the hydrophilic Flag tag was fused to the N terminus of APP-C100) showed a similar degree of neurodegeneration in the hippocampal formation as early as 12 months of age. The 45 control mice displayed only occasional necrotic cells and no extensive cell degeneration in the same brain regions. These findings show that APP-C100 is capable of causing some of the neuropathological features of AD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1523/jneurosci.16-21-06732.1996

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 4 references

Research works printed but not linked: 35

  1. 10.1016/0014-4886(89)90156-8 · DOI
  2. 10.1073/pnas.87.15.6003 · DOI
  3. 10.1097/00005072-199311000-00007 · DOI · Paper page
  4. 10.1016/0006-8993(94)91858-9 · DOI · Paper page
  5. 10.1016/0306-4522(92)90265-4 · DOI · Paper page
  6. 10.1016/S0006-291X(05)80126-3 · DOI
  7. 10.1016/0304-3940(93)90192-N · DOI
  8. 10.1006/exnr.1994.1101 · DOI
  9. 10.1093/hmg/1.7.505 · DOI
  10. Hamos, 1989, Synaptic loss in Alzheimer’s disease and other dementias., Neurology, 39, 355, 10.1212/WNL.39.3.355 · DOI · Paper page
  11. 10.1111/j.1471-4159.1993.tb03194.x · DOI
  12. 10.1126/science.1542796 · DOI
  13. Kalaria, 1992, The blood-brain barrier and cerebral microcirculation in Alzheimer disease., Cerebrovasc Brain Metab Rev, 4, 226
  14. 10.1073/pnas.89.22.10857 · DOI
  15. 10.1523/JNEUROSCI.12-05-01679.1992 · DOI
  16. 10.1016/0006-8993(94)01400-C · DOI
  17. 10.1097/00005072-199311000-00009 · DOI · Paper page
  18. 10.1007/BF00296182 · DOI
  19. Neve RL Boyce FM (1996) Construction and analysis of transgenic mice expressing amyloidogenic fragments of the Alzheimer amyloid protein precursor. in Paradigms of neural injury, methods in neurosciences, Vol 30, ed Perez-Polo JR (Academic, San Diego), pp 298–314. · DOI
  20. 10.1016/0169-328X(86)90033-1 · DOI
  21. 10.1016/0169-328X(87)90012-X · DOI
  22. 10.1073/pnas.89.8.3448 · DOI
  23. 10.1002/cne.901690404 · DOI
  24. 10.1002/jemt.1070280305 · DOI
  25. Prickett, 1989, A calcium-dependent antibody for identification and purification of recombinant proteins., Biotechniques, 7, 580
  26. 10.1038/352239a0 · DOI
  27. 10.1073/pnas.85.19.7341 · DOI
  28. 10.1016/0169-328X(94)90092-2 · DOI
  29. 10.1002/ana.410100209 · DOI · Paper page
  30. Terry, 1990, Physical basis of cognitive alterations in Alzheimer’s disease: synapse loss is the major correlate of cognitive impairment., Ann Neurol, 30, 572, 10.1002/ana.410300410 · DOI · Paper page
  31. 10.1016/0306-4522(94)90310-7 · DOI
  32. 10.1126/science.1857970 · DOI
  33. 10.1126/science.3083509 · DOI
  34. 10.1126/science.2474201 · DOI · Paper page
  35. 10.1038/359064a0 · DOI

Cited by

Sorted by citations

See all 162

Metadata

Authors
Oster-Granite, M. L., McPhie, D. L., Greenan, J., & Neve, R. L.
Venue
The Journal of Neuroscience
Published
1996-11-01
Volume
16
Issue
21
Pages
6732-6741
ISSN
  • 0270-6474
  • 1529-2401
Cited by
162
References
4
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review